Pro-DexFRA:PDXN 63 Interest Coverage is 15.38 as of Mar. 2026, which is 14% below its 10-year median of 17.79. GuruFocus rates FRA:PDXN with a GF Score™ of 63/100 and a GF Value™ of €32.83 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Pro-Dex ranks worse than 52.58% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Pro-Dex's
Operating Income
for the
three
months ended in Mar. 2026 was €2.68 Mil. Pro-Dex's Interest Expense for the
three
months ended in Mar. 2026 was €-0.17 Mil.
Pro-Dex's interest coverage for the quarter that ended in Mar. 2026 was 15.38.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Pro-Dex's Interest Coverage or its related term are showing as below:
FRA:PDXN'
s Interest Coverage Range Over the Past 10 Years
Min: 10.81 Med: 17.79 Max: 486.43
Current: 14.05
FRA:PDXN's Interest Coverage is ranked worse than 52.58% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs FRA:PDXN: 14.05
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Pro-Dex Interest Coverage Related Terms
Pro-Dex Interest Coverage Historical Data
* Premium members only.
The historical data trend for Pro-Dex's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
FRA:PDXN vs KRMD, EMBC, SMTI: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Pro-Dex's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro-Dex Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Pro-Dex's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro-Dex (FRA:PDXN) has a Interest Coverage of 15.38 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Pro-Dex and its competitors. This is 14% below median its historical median of 17.79. Over the past decade, Pro-Dex's Interest Coverage has ranged from 10.81 to 486.43. According to the industry distribution chart, Pro-Dex ranks #245 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 52.6%.
Is Pro-Dex's Interest Coverage too high?
Pro-Dex's current Interest Coverage of 15.38 is 14% below median its 10-year median of 17.79. Over the past 10 years, this metric has ranged from a low of 10.81 to a high of 486.43. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Pro-Dex's value of 15.38 is 3.1% below this industry median. Based on the distribution chart, Pro-Dex ranks #245 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Pro-Dex has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's Interest Coverage compare to KRMD and EMBC?
According to the Medical Devices & Instruments industry distribution chart, Pro-Dex ranks #245 out of 466 companies for Interest Coverage. This places Pro-Dex in the lower half of its industry. The industry median Interest Coverage is 15.88. Pro-Dex's value of 15.38 is 3.1% below this benchmark. Historically, Pro-Dex's own Interest Coverage has ranged from 10.81 to 486.43 over the past decade. While the company's 10-year median is 17.79 vs. the industry median of 15.88, Pro-Dex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro-Dex's current Interest Coverage of 15.38 is 3.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Pro-Dex and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro-Dex's current Interest Coverage is 15.38, which is 14% below median its own 10-year median of 17.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Based on GuruFocus' analysis, Pro-Dex (FRA:PDXN) is currently considered Significantly Overvalued. The stock's GF Value™ is €32.83, compared to a current price of €51.00 — trading 55.3% above its estimated fair value. The current Interest Coverage is 15.38, which is 14% below median its 10-year median of 17.79 and 3.1% below the Medical Devices & Instruments industry median of 15.88. Pro-Dex's overall GF Score™ is 63/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Pro-Dex (FRA:PDXN), the current Interest Coverage is 15.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro-Dex (FRA:PDXN) Overvalued in 2026?
Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued.
The current stock price of €51.00 is trading 55.3% above its estimated GF Value™ of €32.83.
GuruFocus considers Pro-Dex to be Significantly Overvalued.
Key valuation signals for FRA:PDXN:
Interest Coverage: 15.38 (14% below median its 10-year median of 17.79)
GF Value™: €32.83 vs. price of €51.00 (55.3% above fair value)
Industry Position: 3.1% below the Medical Devices & Instruments median (#245 of 466)
No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
63GF Score
Get the complete analysis for FRA:PDXN
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDXN has been successfully added to your 
